Brokerages Set Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Target Price at $28.00
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned a consensus rating of “Hold” from the four ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month […]